DEEJ(SZ:000423) Shang Hai Zheng Quan Bao·2026-01-05 18:24Group 1: Share Buyback Announcement - The company has approved a share buyback plan using its own or raised funds through a concentrated bidding method, with a maximum buyback price of RMB 72.08 per share [2][3] - The estimated minimum number of shares to be repurchased is 138,730 shares, while the maximum is 2,774,700 shares, with the actual number to be determined by the completion of the buyback period [2] - As of December 31, 2025, the company has repurchased a total of 1,628,600 shares, accounting for 0.25% of the total share capital, with a total transaction amount of approximately RMB 79.99 million [2] Group 2: Investment in Healthcare Fund - The company has committed RMB 60 million to participate in the establishment of the China Resources (Chengdu) Pharmaceutical Industry Equity Investment Fund, with a total fund size of RMB 1 billion [8][9] - The fund has completed its registration with the Asset Management Association of China and has received the private fund registration certificate as of December 30, 2025 [10] - The fund aims to invest in the health and wellness sector, leveraging the expertise and resources of the fund manager [8]